BEND3
Basic information
Region (hg38): 6:107065182-107115515
Previous symbols: [ "KIAA1553" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BEND3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 35 | 37 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 35 | 2 | 1 |
Variants in BEND3
This is a list of pathogenic ClinVar variants found in the BEND3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-107068841-C-T | not specified | Uncertain significance (Sep 11, 2024) | ||
6-107068871-G-T | not specified | Uncertain significance (Sep 03, 2024) | ||
6-107069004-G-C | not specified | Uncertain significance (Nov 11, 2024) | ||
6-107069207-C-T | not specified | Uncertain significance (Aug 12, 2024) | ||
6-107069218-C-T | not specified | Uncertain significance (Mar 12, 2024) | ||
6-107069227-T-C | not specified | Uncertain significance (Jan 26, 2023) | ||
6-107069312-T-G | not specified | Uncertain significance (Jun 07, 2024) | ||
6-107069360-T-A | not specified | Uncertain significance (Nov 18, 2022) | ||
6-107069427-G-C | not specified | Uncertain significance (Apr 06, 2023) | ||
6-107069472-G-T | not specified | Uncertain significance (Sep 29, 2023) | ||
6-107069483-T-C | not specified | Uncertain significance (Dec 08, 2023) | ||
6-107069533-C-G | not specified | Uncertain significance (Oct 07, 2024) | ||
6-107069629-C-A | not specified | Uncertain significance (Oct 20, 2024) | ||
6-107069707-C-T | not specified | Uncertain significance (Nov 16, 2021) | ||
6-107069751-G-A | Benign (Mar 30, 2018) | |||
6-107069768-G-A | not specified | Uncertain significance (Feb 15, 2023) | ||
6-107069857-G-A | not specified | Uncertain significance (Jun 16, 2023) | ||
6-107069915-G-A | not specified | Uncertain significance (Aug 13, 2021) | ||
6-107069915-G-T | not specified | Uncertain significance (Apr 25, 2023) | ||
6-107070095-C-T | not specified | Likely benign (Jul 25, 2023) | ||
6-107070128-C-T | not specified | Uncertain significance (Jun 29, 2023) | ||
6-107070136-C-A | not specified | Uncertain significance (Feb 06, 2024) | ||
6-107070163-C-T | not specified | Uncertain significance (Aug 26, 2024) | ||
6-107070212-C-T | not specified | Uncertain significance (Oct 01, 2024) | ||
6-107070269-G-A | not specified | Uncertain significance (Jul 25, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
BEND3 | protein_coding | protein_coding | ENST00000429433 | 3 | 50088 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.936 | 0.0644 | 125739 | 0 | 9 | 125748 | 0.0000358 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.31 | 404 | 558 | 0.724 | 0.0000394 | 5443 |
Missense in Polyphen | 155 | 263.53 | 0.58817 | 2370 | ||
Synonymous | -1.12 | 281 | 258 | 1.09 | 0.0000195 | 1666 |
Loss of Function | 4.03 | 4 | 26.3 | 0.152 | 0.00000123 | 293 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000119 | 0.000119 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000549 | 0.0000544 |
Finnish | 0.0000928 | 0.0000924 |
European (Non-Finnish) | 0.0000177 | 0.0000176 |
Middle Eastern | 0.0000549 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional repressor which associates with the NoRC (nucleolar remodeling complex) complex and plays a key role in repressing rDNA transcription. The sumoylated form modulates the stability of the NoRC complex component BAZ2A/TIP5 by controlling its USP21-mediated deubiquitination (PubMed:21914818, PubMed:26100909). Binds to unmethylated major satellite DNA and is involved in the recruitment of the Polycomb repressive complex 2 (PRC2) to major satellites (By similarity). Stimulates the ERCC6L translocase and ATPase activities (PubMed:28977671). {ECO:0000250|UniProtKB:Q6PAL0, ECO:0000269|PubMed:21914818, ECO:0000269|PubMed:26100909, ECO:0000269|PubMed:28977671}.;
Recessive Scores
- pRec
- 0.111
Intolerance Scores
- loftool
- 0.0480
- rvis_EVS
- -1.06
- rvis_percentile_EVS
- 7.54
Haploinsufficiency Scores
- pHI
- 0.760
- hipred
- Y
- hipred_score
- 0.673
- ghis
- 0.526
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.895
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Bend3
- Phenotype
- homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); pigmentation phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;chromatin silencing at rDNA;DNA methylation;histone H4-K20 trimethylation;histone H3-K9 trimethylation;histone H4 acetylation;protein homooligomerization;histone H3-K4 trimethylation;histone H3-K27 trimethylation;positive regulation of ATP metabolic process
- Cellular component
- nucleoplasm;nuclear heterochromatin;nucleolus
- Molecular function
- rDNA binding;protein binding